SCHEMBL6987034

SCHEMBL6987034

CCCC(Cc1ccccc1)(C(=O)NN)C(=O)[C@@H]([C@H](CCCC1CCCCC1)C(=O)NO)N1CN(C)C=N1.Cc1ccc(S(=O)(=O)O)cc1

nearest known ligand 0.33

Known targets — ChEMBL curated mechanism

ABL1BMXBRAFBTKCHRNA4CHRNB2CSNK1EEGFRERBB2F10FLT1FLT3FLT4IGF1RINSRITKJAK3KDRKITOPRM1PARP1PARP2PDGFRBPIK3CDRAF1RETSLC18A2TECTXKdacAdacBdacCftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
BMP1 P13497 2/20 0.33
MMP2 P08253 3/20 0.32
MMP1 P03956 2/20 0.32
MMP3 P08254 2/20 0.32
FKBP1A P62942 1/20 0.30
REN P00797 1/20 0.30
KDM4E B2RXH2 1/20 0.30
MAPK1 P28482 1/20 0.30
ATM Q13315 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6988468 0.96 MMP2 (0.35) BMP1MMP2MMP1MMP3FKBP1A
SCHEMBL6985386 0.91 FKBP1A (0.32) MMP2MMP1MMP3FKBP1A
SCHEMBL7142417 0.88 MMP2 (0.36) BMP1MMP2MMP1MMP3
SCHEMBL6983355 0.86 BMP1 (0.33) BMP1MMP2MMP1MMP3FKBP1A
SCHEMBL6987230 0.82 BMP1 (0.31) BMP1MMP2REN
SCHEMBL6981859 0.81 BMP1 (0.34) BMP1MMP2MMP1MMP3
SCHEMBL6987345 0.81 MMP2 (0.35) BMP1MMP2MMP1MMP3FKBP1A
SCHEMBL6987820 0.79 MMP2 (0.35) BMP1MMP2MMP1MMP3FKBP1A
SCHEMBL6981500 0.78 ADAM17 (0.34)
SCHEMBL6979963 0.78 PPARG (0.33) BMP1MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1089964-B1 HYDRAZINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2003-10-29 EP disclosed
US-6239151-B1 TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES, OSTEOARTHRITIS, RESPIRATORY DISEASES, TUMORS, CACHEXIA, CARDIOVASCULAR DISEASES, FEVER, HAEMORRHAGE AND SEPSIS, HYDRAZINE DERIVATIVES, HOFFMANN-LA ROCHE INC. 2001-05-29 US disclosed